Bio-IT World January 14, 2026
Irene Yeh

At the 44th Annual J.P. Morgan Healthcare Conference, 10x Genomics announced a strong ending to 2025, generating $166 million in Q4 and totaling more than $520 million at the end of the year. With great anticipation for 2026, 10x Genomics remains centered on their mission on accelerating understanding of biology to advance human health, particularly in the single-cell and spatial biology areas. The key challenge, however, is biology being “very, very complex,” according to Serge Saxonov, CEO and cofounder. “The key to understanding biology is to understand what is going on at the cell level,” explains Saxonov, calling the cell “the fundamental unit of biology.”

Previous generations of tools only produced a general reading of cell...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Biotechnology, Conferences / Podcast, Pharma, Pharma / Biotech, Trends
Related Articles:
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat
Biotech investor Cormorant secures $150M for another SPAC deal

Share Article